Popular Articles From: Lieff Cabraser Announces Class Action Litigation Against Sanofi – SNY to Boeing Begins Construction of Simulation and Analytics Lab Space in Huntsville

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of those who purchased or otherwise acquired the securities of Sanofi (“Sanofi” or the “Company”) (NYSE: SNY) between February 7, 2013 and December 3, 2014, inclusive (the “Class Period”). If you purchased or otherwise acquired Sanofi securities during the Class Period, you may move the Court for appointment as lead plaintiff by no later than February 2, 2015.
Sign-up for Lieff Cabraser Announces Class Action Litigation Against Sanofi – SNY investment picks
By MarketWatch, MarketWatch LONDON (MarketWatch) -- European stocks erased early losses, rising as oil futures pared steep declines and U.S. stock futures turned higher on Tuesday.
Sign-up for UPDATE: European stocks turn higher investment picks
Strongest year for listings at Nasdaq since 2000 with 189 IPOs NEW YORK, Dec.
Sign-up for Nasdaq Secures #1 Position for Total IPOs at U.S. Exchanges in 2014 investment picks
Ventas, Inc. (NYSE: VTR) (“Ventas”) and American Realty Capital Healthcare Trust, Inc. (NASDAQ: HCT) (“HCT”) today announced that the definitive election deadline for HCT’s stockholders to make an election to receive cash consideration, stock consideration or a combination of both, subject to proration, for their shares of HCT common stock upon completion of the merger of HCT with and into a wholly owned subsidiary of Ventas, pursuant to the Agreement and Plan of Merger, dated as of June 1, 2014, as amended (the “Merger Agreement”), by and among Ventas, HCT, Stripe Sub, LLC, Stripe OP, LP and American Realty Capital Healthcare Trust Operating Partnership, L.P., will be 5:00 p.m. Eastern Time on January 14, 2015 (the “Election Deadline”). For HCT stockholders to make a timely election, a properly completed letter of election and transmittal must be received by Wells Fargo
Sign-up for Ventas and American Realty Capital Healthcare Trust, Inc. Announce Definitive Election Deadline for HCT Stockholders to Make an Election to Receive Cash or Stock in the Merger investment picks
Alliance Combines Amgen's Oncology Targets and Kite's Leading CAR T Cell Therapy Platform to Develop new Therapeutic Candidates Kite to Receive a $60 Million Upfront Payment From Amgen and Eligible for up to $525 Million in Regulatory and Sales Milestone Payments per Amgen Program; Plus, Tiered High Single- to Double-Digit Royalties for Sales and License of Kite's Intellectual Property for CAR T Cell Products Amgen Eligible to Receive up to $525 Million in Milestone Payments per Kite Program; Plus, Tiered Single-Digit Sales Royalties Kite to Host Conference Call Today at 4:00 PM Eastern Time THOUSAND OAKS, Calif.
Sign-up for Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies investment picks
-- Fourth quarter placements of Catalyst® and premium hematology analyzers in total increased 21% --
Sign-up for IDEXX Instrument Placement Momentum Reinforces Strong Organic Revenue Growth Outlook investment picks
--Transactions transform Egalet into a commercial specialty pharmaceutical company paving the way for commercialization of late-stage pipeline of abuse-deterrent opioids -- --
Sign-up for Egalet Acquires/Licenses Two Innovative Approved Pain Products investment picks
InvenSense, Inc. (NYSE: INVN), the leading provider of intelligent sensor solutions, announced that since starting shipment of MEMS-based sensors in late 2006, it will reach 1 billion devices shipped in Q1 of calendar 2015.
Sign-up for InvenSense® to Ship Over 1 Billion MEMS Sensors Worldwide investment picks
By Jennifer Booton, MarketWatch Chinese smartphone vendors now comprise 30% of global volume NEW YORK (MarketWatch) -- With Apple Inc. selling a record number of iPhones in the fourth quarter, one would think the market for smartphones would be hotter than ever.
Sign-up for UPDATE: 5 predictions for mobile devices in 2015 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1169268&ProfileId=051205&sourceType=1 PARSIPPANY, NJ --
Sign-up for Ogilvy CommonHealth Worldwide Takes Home Silver at PM360's Pharma Choice Awards investment picks
http://www.ccnmatthews.com/logos/20110811-bdi-logo.jpg CALGARY, ALBERTA --
Sign-up for Black Diamond Group Limited Provides Operational Update investment picks
Strengthening Couche-Tard's Position in Attractive Southeastern and Gulf Coast United States LAVAL, QC and CARY, NC , Dec.
Sign-up for Alimentation Couche-Tard Inc. and The Pantry, Inc. Announce Definitive Merger Agreement investment picks
Starbucks Coffee Company (NASDAQ: SBUX) chairman, president and chief executive officer Howard Schultz and other company leaders will detail Starbucks five-year strategic growth plan today at its biennial Investor Day, hosted at the company’s Support Center in Seattle for the first time in a decade.
Sign-up for Starbucks Details Five-Year Plan to Accelerate Profitable Growth and Extend Markets, Channels and Formats around the World at Biennial Investor Conference investment picks
Prudential market experts expect moderate growth in 2015 – led by the United States – as global economies continue to recover.
Sign-up for Prudential experts: Investors should prepare for a lower return environment relative to historic returns investment picks
SAN DIEGO and BOISE, Idaho , Jan.
Sign-up for Robbins Arroyo LLP: Acquisition of MWI Veterinary Supply, Inc. (MWIV) by AmerisourceBergen Corporation (ABC) May Not Be in Shareholders' Best Interests investment picks
Sign-up for AllianceBernstein Launches Multi-Manager Target-Date Series Co-managed with Morningstar Associates investment picks
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS ), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced the launch of its first product, Infimab (BOW015), the first infliximab biosimilar in India.
Sign-up for EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches in India investment picks
Byron R.
Sign-up for Byron Wien Announces Predictions for Ten Surprises for 2015 investment picks
Garmin International, Inc., a unit of Garmin Ltd.
Sign-up for Introducing Garmin® epix™: The First-of-its-Kind Hands-free Navigation Device investment picks
Gilead Sciences, Inc. (Nasdaq:GILD) and Phenex Pharmaceuticals AG, a privately-held biotechnology company, today announced the signing of a definitive agreement under which Gilead will acquire Phenex’s Farnesoid X Receptor (FXR) program comprising small molecule FXR agonists for the treatment of liver diseases including nonalcoholic steatohepatitis (NASH). Under the terms of the agreement, Gilead will pay Phenex an upfront payment plus additional payments based upon achievement of certain development milestones that may potentially be worth up to $470 million.
Sign-up for Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases investment picks
MIDLAND, Texas, Jan.
Sign-up for Legacy Reserves LP to Participate at the UBS MLP One-on-One Conference investment picks
http://www.ccnmatthews.com/logos/20100823-cnelogo.jpg CALGARY, ALBERTA --
Sign-up for Canacol Provides Update on Calendar 2015 Corporate Budget and Exploration Operations and Announces Oil Discovery in Colombia investment picks
-Catey Hill; 415-439-6400; AskNewswires@dowjones.com 6.
Sign-up for UPDATE: 10 things grocery stores won't tell you -2- investment picks
Yum! Brands, Inc. (NYSE: YUM), in advance of its Annual Investor Meeting, now estimates mid-single-digit full-year 2014 EPS growth versus prior year, excluding Special Items.
Sign-up for Yum! Brands Expects Full-Year 2015 EPS Growth of At Least 10%; Will Host Investor Update Meeting on Thursday, December 11, 2014 investment picks
By Tim Mullaney Saving $500 a year isn't a concern for a wealthy owner of a $100,000 car As the price of gasoline cratered, so have shares of Tesla Motors, down more than a quarter since Sept.
Sign-up for Why $2 gas is no problem for $200-a-share Tesla investment picks
Production Up 7.5 Bcf/d Versus December 2013 DENVER , Jan.
Sign-up for U.S. Natural Gas Production in December Averages 72.8 Bcf/d, Achieves New Record: Platts Bentek Energy investment picks
Boeing adds 7,000 square feet of lab space to research center; construction will be complete in mid-2015 HUNTSVILLE, Ala.
Sign-up for Boeing Begins Construction of Simulation and Analytics Lab Space in Huntsville investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar

Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Popular Articles From: Lieff Cabraser Announces Class Action Litigation Against Sanofi – SNY to Boeing Begins Construction of Simulation and Analytics Lab Space in Huntsville
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent